Olink Bioscience, a Sweden-based biotechnology company focused on innovative protein detection technologies, has entered into a distribution agreement with Bethyl Laboratories. Together with Bethyl Olink Bioscience will continue to expand the distribution of the Duolink® product line in the US market.
"We are excited to enter into an agreement with Bethyl to distribute our Duolink product line in the USA. With an excellent reputation as a provider of first-class products we believe Bethyl will help us expand the market for our products in the region," comments Simon Fredriksson, president and CEO, Olink.
"Bethyl is an established provider of premium-quality antibody products and services for clinical and research applications and through the distribution agreement with Olink we now have the opportunity to offer a complete solution of antibodies together with a highly specific protein detection technology," says John Carwile, CEO, Bethyl Laboratories.
Twitter